Insulin pumps are a medical device used by people with diabetes to automatically deliver a measured dose of insulin into their bloodstream. Traditionally they have involved a canula and separate ...

Modern insulin pumps are self-contained devices that attach to a user’s skin via an adhesive patch, and are responsible for administering insulin as needed. Curious as to what was inside ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

Tap tap tap tap. Narrator The pump that Melissa uses implants a small tube just under the skin which delivers a steady dose of insulin. That's usually the job of the pancreas. But in type one ...

Insulet has launched the Omnipod 5 automated insulin delivery app for iPhone in the US. The app obviates the need for ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

It is the last bullet point that’s creating issues. During the 2023 Open Enrollment Period, I discovered that some clients’ insulin would not be covered by their plans in the new year.

Katie Sullivan, DNP, FNP-C, is publicizing her own challenge with updating an insulin pump as part of an effort to bring an end to the biannual seasonal clock changes in the United States.

Citation: New type of insulin that switches on and off could help diabetics avoid sudden drops in blood sugar levels (2024, October 16) retrieved 8 November 2024 from https://medicalxpress.com ...

Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. Shares of the medical device maker rose about 2.5% to $251 in extended trading.